Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Dr. Michael Joyner discusses whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death.

Image courtesy of Michael Joyner

Image courtesy of the interviewee


Report Infringement

Sign-up

Leave a Reply

Your email address will not be published. Required fields are marked *

×
As a Guest, you have insight(s) remaining for this month. Create a free account to get started.
Related Posts

Enter the Surface-Interface

Sabina Andron uses the concept of interface to discuss the vertical surfaces of the built environment as interactive locations of spatial production and regulation.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×